Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000035813Phase 4Recruiting
Phase 4, randomised trial comparing Remimazolam tosylate group with Propofol group (2 arms). Primary endpoint: MOAA/S score. Started Aug 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000035813.